Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Bullish on CrowdStrike Holdings Raise Price Targets

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
Technology Blockchain Trading online
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

Analyst Fatima Boolani from Citigroup is optimistic about CrowdStrike Holdings (NASDAQ: CRWD), maintaining a Buy rating and increasing the price target to $425 on March 7, 2024. This adjustment signifies a strong belief in the company’s future performance. In line with this positive sentiment, UBS has also raised their price target on CrowdStrike Holdings to $385 from $300, while also upholding a Buy rating. These moves demonstrate a high level of confidence in the growth prospects of CrowdStrike Holdings.

CRWD Stock Performance Review: Mixed Results on March 7, 2024

On March 7, 2024, CrowdStrike Holdings Inc. (CRWD) had a mixed performance in the stock market. The stock was trading near the top of its 52-week range and above its 200-day simple moving average, indicating strong price momentum.

At the close of the market, CRWD shares were priced at $329.68, representing a slight increase of $0.11 or 0.03% from the previous trading day. However, after-hours trading told a different story as the stock dropped $3.28, erasing some of the gains made during the regular trading hours. Overall, CRWD’s performance on March 7th was somewhat mixed, with a modest gain during regular trading hours followed by a decline in after-hours trading. Investors will be keeping a close eye on future developments to see how the stock performs in the coming days.

CrowdStrike Holdings, Inc. (CRWD) Reports Strong Financial Performance and Growth Trajectory on March 7, 2024

CrowdStrike Holdings, Inc. (CRWD) has been making waves in the cybersecurity industry, and its stock performance on March 7, 2024, reflects the company’s strong financial performance. According to data from CNN Money, CRWD reported total revenue of $3.06 billion for the past year, with a significant increase of 36.33% compared to the previous year. The company also reported a net income of $89.33 million for the past year, marking an impressive increase of 148.75% compared to the previous year. Earnings per share (EPS) for the past year was reported at $0.37, showing a substantial increase of 146.64% compared to the previous year. Overall, CRWD’s stock performance on March 7, 2024, reflects the company’s strong financial performance and growth trajectory. Investors and analysts will be closely monitoring the company’s future financial reports and market performance to assess its long-term growth potential.

Tags: CRWD
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Trading online

Record Surge in Lytus Technologies Stocks Signals Promising Growth for Investors

Finance_Commercial

Title Trading of CERo Therapeutics Shares Halted Due to Circuit Breaker Trigger

Healthcare cloud based

Revolutionizing Medical Treatments Creative Technologies Latest Patent Applications

Recommended

Coinbase Stock

Coinbase Expands Its Strategic Footprint Across Multiple Fronts

1 month ago
AnaptysBio Stock

AnaptysBio Shares Approach Critical Juncture as Key Events Loom

7 months ago
Origin Materials Stock

Can Origin Materials Stock Recover From Its Steep Decline?

4 months ago
Cassava Sciences Stock

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Glencore Shares Demonstrate Resilience Amid Copper Market Weakness

Energiekontor Stock Gains Momentum from Policy Shifts

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

Ocugen Shares Slide Despite Positive Clinical Trial Results

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Trending

TeamViewer Stock
Analysis

TeamViewer’s SDAX Debut Coincides With Share Price Weakness

by SiterGedge
March 25, 2026
0

TeamViewer's formal move to Germany's SDAX index represents more than a symbolic shift, occurring alongside a cautious...

Shell Stock

Shell Shares Face Analyst Downgrade Following Quarterly Results

March 25, 2026
Heidelberg Materials Stock

Heidelberg Materials Stock Gains on Strong Fundamentals

March 25, 2026
Glencore Stock

Glencore Shares Demonstrate Resilience Amid Copper Market Weakness

March 25, 2026
Energiekontor Stock

Energiekontor Stock Gains Momentum from Policy Shifts

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • TeamViewer’s SDAX Debut Coincides With Share Price Weakness
  • Shell Shares Face Analyst Downgrade Following Quarterly Results
  • Heidelberg Materials Stock Gains on Strong Fundamentals

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com